Association of BRCA1 /2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta‐analysis
Author:
Affiliation:
1. Department of Gynaecology Hebei General Hospital Shijiazhuang China
Publisher
Wiley
Subject
Obstetrics and Gynecology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.15326
Reference75 articles.
1. First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
2. BRCA Gene Structure and Function in Tumor Suppression
3. Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
4. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
5. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations;Satagopan JM;Clin Cancer Res,2002
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomarkers in Ovarian Cancer: Towards Personalized Medicine;Proteomes;2024-03-18
2. Dynamic Monitoring of CD200 Mediated by Ascites-Derived Exosomes as a Predictor of Survival and Response to Front-Line Chemotherapeutics in Advanced High-Grade Serous Ovarian Cancer;Clinical and Experimental Obstetrics & Gynecology;2023-10-19
3. miR-34a-FOXP1 Loop in Ovarian Cancer;ACS Omega;2023-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3